Robert Vandersluis

VP of Artificial Intelligence (AI), GSK
Panelist

Robert Vandersluis is VP of Artificial Intelligence (AI) at GSK, where he explores the ethical and public policy implications of using AI systems in drug discovery and clinical applications. As part of these efforts, Robert leads academic collaborations with Stanford University and the University of Adelaide, which undertake independent research aimed at promoting AI-based interventions that are inclusive, empowering, and safe. Prior to his work in AI, Robert managed a £20 billion investment portfolio, and he served as a non-executive director for various investment funds with £40 billion of assets under management.

Robert was educated at Oxford, Cambridge, Harvard, Michigan, and the LSE—where he explored several different fields, including economics, politics, public policy, philosophy, ethics, and artificial intelligence. Robert’s other interests include swimming, sailing, and Vespa riding. He lives in London with his wife, Sarah.

Robert Vandersluis